MX2022008440A - Inhaladores de dosis medida presurizada que comprenden una formulacion farmaceutica amortiguada. - Google Patents
Inhaladores de dosis medida presurizada que comprenden una formulacion farmaceutica amortiguada.Info
- Publication number
- MX2022008440A MX2022008440A MX2022008440A MX2022008440A MX2022008440A MX 2022008440 A MX2022008440 A MX 2022008440A MX 2022008440 A MX2022008440 A MX 2022008440A MX 2022008440 A MX2022008440 A MX 2022008440A MX 2022008440 A MX2022008440 A MX 2022008440A
- Authority
- MX
- Mexico
- Prior art keywords
- metered dose
- pharmaceutical formulation
- pressurised metered
- dose inhalers
- buffered pharmaceutical
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 238000009472 formulation Methods 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- KUVIULQEHSCUHY-XYWKZLDCSA-N Beclometasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(Cl)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)COC(=O)CC)(OC(=O)CC)[C@@]1(C)C[C@@H]2O KUVIULQEHSCUHY-XYWKZLDCSA-N 0.000 abstract 1
- 239000000443 aerosol Substances 0.000 abstract 1
- 229950000210 beclometasone dipropionate Drugs 0.000 abstract 1
- BPZSYCZIITTYBL-UHFFFAOYSA-N formoterol Chemical compound C1=CC(OC)=CC=C1CC(C)NCC(O)C1=CC=C(O)C(NC=O)=C1 BPZSYCZIITTYBL-UHFFFAOYSA-N 0.000 abstract 1
- 229960002848 formoterol Drugs 0.000 abstract 1
- 229940071648 metered dose inhaler Drugs 0.000 abstract 1
- 208000023504 respiratory system disease Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
- C09D127/00—Coating compositions based on homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a halogen; Coating compositions based on derivatives of such polymers
- C09D127/02—Coating compositions based on homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a halogen; Coating compositions based on derivatives of such polymers not modified by chemical after-treatment
- C09D127/12—Coating compositions based on homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a halogen; Coating compositions based on derivatives of such polymers not modified by chemical after-treatment containing fluorine atoms
- C09D127/18—Homopolymers or copolymers of tetrafluoroethene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/009—Inhalators using medicine packages with incorporated spraying means, e.g. aerosol cans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/02—General characteristics of the apparatus characterised by a particular materials
- A61M2205/0238—General characteristics of the apparatus characterised by a particular materials the material being a coating or protective layer
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Anesthesiology (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Otolaryngology (AREA)
- Inorganic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Dispersion Chemistry (AREA)
- Materials Engineering (AREA)
- Wood Science & Technology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La presente invención se relaciona de manera general con una formulación en aerosol que comprende formoterol y dipropionato de beclometasona, la formulación está contenida en una lata recubierta, particularmente útil para usarse en un inhalador de dosis medida presurizada para el tratamiento de enfermedades respiratorias.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP20153973 | 2020-01-28 | ||
EP20214091 | 2020-12-15 | ||
PCT/EP2021/051669 WO2021151857A1 (en) | 2020-01-28 | 2021-01-26 | Pressurised metered dose inhalers comprising a buffered pharmaceutical formulation |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2022008440A true MX2022008440A (es) | 2022-08-02 |
Family
ID=74285492
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2022008440A MX2022008440A (es) | 2020-01-28 | 2021-01-26 | Inhaladores de dosis medida presurizada que comprenden una formulacion farmaceutica amortiguada. |
Country Status (16)
Country | Link |
---|---|
US (1) | US20230347080A1 (es) |
EP (1) | EP4096623A1 (es) |
JP (1) | JP2023511615A (es) |
KR (1) | KR20220133193A (es) |
CN (3) | CN115003282A (es) |
AU (1) | AU2021213883A1 (es) |
BR (1) | BR112022012361A2 (es) |
CA (1) | CA3163599A1 (es) |
CL (1) | CL2022002008A1 (es) |
CO (1) | CO2022012207A2 (es) |
GB (1) | GB2593283B (es) |
GE (1) | GEP20247594B (es) |
IL (1) | IL294804A (es) |
MX (1) | MX2022008440A (es) |
PE (1) | PE20221867A1 (es) |
WO (1) | WO2021151857A1 (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2024033941A1 (en) * | 2022-08-10 | 2024-02-15 | Cipla Limited | A pharmaceutical composition of salbutamol and pharmaceutical green propellant |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RO119116B1 (ro) | 1995-04-14 | 2004-04-30 | Glaxo Wellcome Inc. | Inhalator pentru dozarea salmeterolului |
DZ3358A1 (fr) | 2000-05-22 | 2001-11-29 | Chiesi Farma Spa | Formulations en solution pharmaceutiques pour inhalateurs-doseurs sous pression |
EP1241113A1 (en) * | 2001-03-12 | 2002-09-18 | CHIESI FARMACEUTICI S.p.A. | Inhaler with means for improving chemical stability of medicinal aerosol solution contained therein |
HUE044926T2 (hu) | 2002-03-01 | 2019-11-28 | Chiesi Farm Spa | Szuperfinom formoterolkészítmény |
US9308199B2 (en) | 2004-04-29 | 2016-04-12 | Honeywell International Inc. | Medicament formulations |
CN1301747C (zh) * | 2004-11-30 | 2007-02-28 | 深圳市海王英特龙生物技术股份有限公司 | 一种蛋白药物微囊及其吸入性气雾剂 |
FR2895260B1 (fr) * | 2005-12-23 | 2009-02-20 | Servier Lab | Nouvelle composition pharmaceutique a base d'huile essentielle pour pulverisation nasale et/ou buccale |
GB201108039D0 (en) | 2011-05-13 | 2011-06-29 | Mexichem Amanco Holding Sa | Compositions |
PL3089735T3 (pl) * | 2013-12-30 | 2018-12-31 | Chiesi Farmaceutici S.P.A. | Trwała ciśnieniowa kompozycja roztworu aerozolowego kombinacji bromku glikopironium i formoterolu |
TR201809356T4 (tr) * | 2013-12-30 | 2018-07-23 | Chiesi Farm Spa | Gli̇kopi̇ronyum bromür ve formoterol kombi̇nasyonunun stabi̇l basinçli aerosol çözelti̇ kompozi̇syonu. |
WO2016018892A1 (en) * | 2014-07-29 | 2016-02-04 | 3M Innovative Properties Company | Method of preparing a pharmaceutical composition |
BR122020022602B1 (pt) * | 2015-12-04 | 2024-03-05 | Mexichem Fluor S.A. De C.V. | Composição farmacêutica |
US10098837B2 (en) * | 2016-07-28 | 2018-10-16 | Chiesi Farmaceutici S.P.A. | Combination therapy for COPD |
GB2554091A (en) * | 2016-09-19 | 2018-03-28 | Mexichem Fluor Sa De Cv | Pharmaceutical composition |
CN116898804A (zh) * | 2016-09-19 | 2023-10-20 | 墨西哥氟石股份公司 | 药物组合物 |
AU2017328907B2 (en) | 2016-09-19 | 2020-04-09 | Mexichem Fluor S.A. De C.V. | Pharmaceutical composition |
GB2558191A (en) * | 2016-09-19 | 2018-07-11 | Mexichem Fluor Sa De Cv | Pharmaceutical composition |
GB2554088A (en) * | 2016-09-19 | 2018-03-28 | Mexichem Fluor Sa De Cv | Pharmaceautical composition |
US20210275439A1 (en) * | 2018-06-07 | 2021-09-09 | Kindeva Drug Delivery L.P. | Fluticasone and vilanterol formulation and inhaler |
-
2021
- 2021-01-26 CN CN202180010439.0A patent/CN115003282A/zh active Pending
- 2021-01-26 JP JP2022545798A patent/JP2023511615A/ja active Pending
- 2021-01-26 CN CN202311490675.4A patent/CN117599290A/zh active Pending
- 2021-01-26 EP EP21702003.1A patent/EP4096623A1/en active Pending
- 2021-01-26 IL IL294804A patent/IL294804A/en unknown
- 2021-01-26 GE GEAP202116025A patent/GEP20247594B/en unknown
- 2021-01-26 AU AU2021213883A patent/AU2021213883A1/en active Pending
- 2021-01-26 CN CN202110100918.3A patent/CN113244490A/zh active Pending
- 2021-01-26 US US17/760,354 patent/US20230347080A1/en active Pending
- 2021-01-26 GB GB2101048.3A patent/GB2593283B/en active Active
- 2021-01-26 BR BR112022012361A patent/BR112022012361A2/pt unknown
- 2021-01-26 WO PCT/EP2021/051669 patent/WO2021151857A1/en active Application Filing
- 2021-01-26 PE PE2022001478A patent/PE20221867A1/es unknown
- 2021-01-26 MX MX2022008440A patent/MX2022008440A/es unknown
- 2021-01-26 KR KR1020227024888A patent/KR20220133193A/ko unknown
- 2021-01-26 CA CA3163599A patent/CA3163599A1/en active Pending
-
2022
- 2022-07-26 CL CL2022002008A patent/CL2022002008A1/es unknown
- 2022-08-26 CO CONC2022/0012207A patent/CO2022012207A2/es unknown
Also Published As
Publication number | Publication date |
---|---|
GB202101048D0 (en) | 2021-03-10 |
GEP20247594B (en) | 2024-02-12 |
CO2022012207A2 (es) | 2022-11-08 |
PE20221867A1 (es) | 2022-12-02 |
BR112022012361A2 (pt) | 2022-09-06 |
KR20220133193A (ko) | 2022-10-04 |
CL2022002008A1 (es) | 2023-02-24 |
IL294804A (en) | 2022-09-01 |
CN115003282A (zh) | 2022-09-02 |
CN117599290A (zh) | 2024-02-27 |
JP2023511615A (ja) | 2023-03-20 |
CN113244490A (zh) | 2021-08-13 |
GB2593283A (en) | 2021-09-22 |
WO2021151857A1 (en) | 2021-08-05 |
US20230347080A1 (en) | 2023-11-02 |
EP4096623A1 (en) | 2022-12-07 |
CA3163599A1 (en) | 2021-08-05 |
GB2593283B (en) | 2023-09-13 |
AU2021213883A1 (en) | 2022-07-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2022009643A (es) | Inhaladores dosificadores presurizados que comprenden una formulacion farmaceutica amortiguada. | |
Virchow et al. | Importance of inhaler devices in the management of airway disease | |
CY1122851T1 (el) | Υπερλεπτο σκευασμα φορμοτερολης | |
JP5886630B2 (ja) | 重度で抑制されていないぜんそくの治療方法、装置、および組成物 | |
AR098982A1 (es) | Composición combinada de bromuro de glicopirronio y formoterol en solución estable presurizada para aerosol | |
AR079726A1 (es) | Terapia combinada para enfermedad pulmonar obstructiva cronica (epoc) . composicion farmaceutica.frasco de aerosol. metodo.conjunto de componentes | |
NZ599900A (en) | Pharmaceutical suspension aerosol formulations for use in metered dose inhalers | |
MX2021012723A (es) | Inhalador de presión positiva para entrega de medicamento inhalable y métodos para uso. | |
WO2006124954A3 (en) | Inhalable formulations of amphotericin b and methods and devices for delivery thereof | |
MX2023003754A (es) | Formulacion farmaceutica para inhalador presurizado de dosis medidas. | |
HRP20160630T1 (hr) | Farmaceutske aerosolne formulacije formoterola i beklometazon-dipropionata | |
MX2022008440A (es) | Inhaladores de dosis medida presurizada que comprenden una formulacion farmaceutica amortiguada. | |
Bisgaard | Automatic actuation of a dry powder inhaler into a nonelectrostatic spacer | |
NZ591174A (en) | Metered dose inhaler | |
US10383883B2 (en) | Treatment of congestion using steroids and adrenergics | |
GB201118188D0 (en) | Manufacture of medicinal aerosol canisters | |
NZ600208A (en) | Inhalation solutions | |
SE0303091D0 (sv) | Combined doses of tiotropium andfluticasone | |
US20230302233A1 (en) | Edta for treatment of cystic fibrosis and other pulmonary diseases and disorders | |
Anderson et al. | Aerosolized drug delivery in awake and anesthetized children to treat bronchospasm | |
Vos et al. | In-silico assessment of airway deposition using functional respiratory imaging for mono, dual and triple combination co-suspension metered dose inhaler formulations | |
US20230271770A1 (en) | Anti-Viral Pharmaceutical Formulations Administered Via Devices for Lung Targeted Delivery | |
Bokhatwa et al. | Aerosol | |
Vos et al. | C69 HERE'S LOOKING AT YOU: IMAGING STUDIES IN COPD: In-Silico Assessment Of Airway Deposition Using Functional Respiratory Imaging For Mono, Dual And Triple Combination Co-Suspension Metered Dose Inhaler Formulations | |
Babu et al. | Gaseous Dosage Forms |